Thomas Talbot

Thomas Talbot, professor of medicine and chief hospital epidemiologist at Vanderbilt University Medical Center, shares what is known about the omicron variant and provides reminders on how to stay protected this season. Read More

Thomas Talbot, professor of medicine and chief hospital epidemiologist at Vanderbilt University Medical Center, shares the latest available information on when COVID-19 vaccines will be approved for children under 12. Read More

Thomas Talbot, professor of medicine and chief hospital epidemiologist at Vanderbilt University Medical Center, shares what we know about when COVID-19 vaccines will be fully approved. Read More

Thomas Talbot, professor of medicine and chief hospital epidemiologist at Vanderbilt University Medical Center, discusses what we know about the delta variant of COVID-19.  Read More

Thomas Talbot, professor of medicine and chief hospital epidemiologist at Vanderbilt University Medical Center, shares why it's important for people to get vaccinated, even if they've already had COVID-19. Read More

Patients who take a cholesterol-lowering statin drug while taking the antibiotic daptomycin have increased risk of developing muscle weakness or a more severe form of muscle damage. Read More

A “bundle” of electronically implemented care guidelines reduced intensive care unit patient complications related to mechanical ventilation. Read More

U.S. Sen. Lamar Alexander, BA’62, discussed the Ebola epidemic with Vanderbilt physicians during a September visit to campus. Read More

In an effort to protect both employees and patients at Vanderbilt University Medical Center from potential harm, the Medical Center is revising its influenza vaccination plan and mandating the influenza vaccine for all VUMC employees. Read More

(iStockphoto) As the Ebola virus strengthens in West Africa and authorities work to prevent the virus from spreading in the United States, Vanderbilt University Medical Center continues its preparations to: safely treat patients with Ebola; educate the general public through the Tennessee Poison Center hotline; and ensure… Read More

Thomas Talbot, M.D., MPH, associate professor of Medicine and Chief Hospital Epidemiologist at Vanderbilt University Medical Center, received the 2013 Investigator Award from the Society for Healthcare Epidemiology of America (SHEA) at the organization’s Annual Scientific Meeting last week in San Francisco. Read More

Research in the last two years to examine the effectiveness of the influenza vaccine has raised public doubt about the flu shot's effectiveness. But two Vanderbilt researchers co-wrote an editorial in the Journal of the American Medical Association (JAMA) recently to help balance the current debate. Read More

Efforts to improve quality of care at Vanderbilt have expanded rapidly in recent years. Notable achievements such as the central line-associated blood stream infections (CLABSI) reduction program — recently lauded for achieving infection levels significantly lower than the national average — have put Vanderbilt in the spotlight as a… Read More

Implementation of antibiotic stewardship tactics as part of infection reduction campaigns sees significant results. Read More